Cargando…

Impact of 2′-Fucosyllactose on Gut Microbiota Composition in Adults with Chronic Gastrointestinal Conditions: Batch Culture Fermentation Model and Pilot Clinical Trial Findings

Intestinal dysbiosis has been described in patients with certain gastrointestinal conditions including irritable bowel syndrome (IBS) and ulcerative colitis. 2′-fucosyllactose (2′-FL), a prebiotic human milk oligosaccharide, is considered bifidogenic and butyrogenic. To assess prebiotic effects of 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryan, Jennifer Joan, Monteagudo-Mera, Andrea, Contractor, Nikhat, Gibson, Glenn R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998190/ https://www.ncbi.nlm.nih.gov/pubmed/33799455 http://dx.doi.org/10.3390/nu13030938

Ejemplares similares

Impact of inorganic iron and haem on the human gut microbiota; An in vitro batch-culture approach
por: Monteagudo-Mera, Andrea, et al.
Publicado: (2023)

Determination of the prebiotic activity of wheat arabinogalactan peptide (AGP) using batch culture fermentation
por: Harris, Suzanne, et al.
Publicado: (2019)

A key genetic factor for fucosyllactose utilization affects infant gut microbiota development
por: Matsuki, Takahiro, et al.
Publicado: (2016)

Differential responses of gut microbiota to the same prebiotic formula in oligotrophic and eutrophic batch fermentation systems
por: Long, Wenmin, et al.
Publicado: (2015)

2′-Fucosyllactose Ameliorates Inflammatory Bowel Disease by Modulating Gut Microbiota and Promoting MUC2 Expression
por: Yao, Qianqian, et al.
Publicado: (2022)

Malnutrition and Gut Microbiota in Children
por: Iddrisu, Ishawu, et al.
Publicado: (2021)

A Comparison of the In Vitro Effects of 2’Fucosyllactose and Lactose on the Composition and Activity of Gut Microbiota from Infants and Toddlers
por: Van den Abbeele, Pieter, et al.
Publicado: (2021)

Batch fermentation : modeling, monitoring, and control /
Publicado: (2003)

The effect of 2′-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose
por: Salli, Krista, et al.
Publicado: (2019)

Multiple Batches of Fermentation Promote the Formation of Functional Microbiota in Chinese Miscellaneous-Flavor Baijiu Fermentation
por: Liu, Pulin, et al.
Publicado: (2020)

Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2019)

Healthy adult gut microbiota sustains its own vitamin B12 requirement in an in vitro batch fermentation model
por: Kundra, Palni, et al.
Publicado: (2022)

2′-Fucosyllactose Supplementation Improves Gut-Brain Signaling and Diet-Induced Obese Phenotype and Changes the Gut Microbiota in High Fat-Fed Mice
por: Lee, Sunhye, et al.
Publicado: (2020)

2-Fucosyllactose Metabolism by Bifidobacteria Promotes Lactobacilli Growth in Co-Culture
por: Nogacka, Alicja M., et al.
Publicado: (2023)

In Vitro Probiotic Modulation of the Intestinal Microbiota and 2′Fucosyllactose Consumption in Fecal Cultures from Infants at Two Months of Age
por: Nogacka, Alicja M., et al.
Publicado: (2022)

Multi‐level metabolic engineering of Escherichia coli for high‐titer biosynthesis of 2′‐fucosyllactose and 3‐fucosyllactose
por: Li, Mengli, et al.
Publicado: (2022)

Fermented Foods: Definitions and Characteristics, Impact on the Gut Microbiota and Effects on Gastrointestinal Health and Disease
por: Dimidi, Eirini, et al.
Publicado: (2019)

The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
por: Wang, Yuanyifei, et al.
Publicado: (2020)

Metabolic Fate and Distribution of 2´‐Fucosyllactose: Direct Influence on Gut Microbial Activity but not on Brain
por: Kuntz, Sabine, et al.
Publicado: (2019)

Author Correction: Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2020)

Influence of 2′-Fucosyllactose on the Microbiota Composition and Metabolic Activity of Fecal Cultures from Breastfed and Formula-Fed Infants at Two Months of Age
por: Nogacka, Alicja M., et al.
Publicado: (2021)

Infant Fecal Fermentations with Galacto-Oligosaccharides and 2′-Fucosyllactose Show Differential Bifidobacterium longum Stimulation at Subspecies Level
por: Lindner, Cordula, et al.
Publicado: (2023)

Restraint stress induced gut dysmotility is diminished by a milk oligosaccharide (2′-fucosyllactose) in vitro
por: Farhin, Sohana, et al.
Publicado: (2019)

Combining galacto-oligosaccharides and 2′-fucosyllactose alters their fermentation kinetics by infant fecal microbiota and influences AhR-receptor dependent cytokine responses in immature dendritic cells
por: Akkerman, Renate, et al.
Publicado: (2022)

Carotenoid Production by Rhodotorula mucilaginosa in Batch and Fed-Batch Fermentation Using Agroindustrial Byproducts
por: Dias Rodrigues, Tábita Veiga, et al.
Publicado: (2019)

A Single-Batch Fermentation System to Simulate Human Colonic Microbiota for High-Throughput Evaluation of Prebiotics
por: Takagi, Risa, et al.
Publicado: (2016)

Effect of a Nutrition Support Formula in Adults With Inflammatory Bowel Disease: A Pilot Study
por: Ryan, Jennifer J, et al.
Publicado: (2019)

2′-Fucosyllactose Remits Colitis-Induced Liver Oxygen Stress through the Gut–Liver–Metabolites Axis
por: Yao, Qianqian, et al.
Publicado: (2022)

Fermentation properties and potential prebiotic activity of Bimuno(®) galacto-oligosaccharide (65 % galacto-oligosaccharide content) on in vitro gut microbiota parameters
por: Grimaldi, Roberta, et al.
Publicado: (2016)

Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697
por: Zabel, Bryan E., et al.
Publicado: (2020)

Kinetic study of batch and fed-batch enzymatic saccharification of pretreated substrate and subsequent fermentation to ethanol
por: Gupta, Rishi, et al.
Publicado: (2012)

2′-Fucosyllactose Ameliorates Oxidative Stress Damage in d-Galactose-Induced Aging Mice by Regulating Gut Microbiota and AMPK/SIRT1/FOXO1 Pathway
por: Wang, Jin, et al.
Publicado: (2022)

The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, l-carnitine and related precursors by the human gut microbiota
por: Day-Walsh, Priscilla, et al.
Publicado: (2021)

One Health, Fermented Foods, and Gut Microbiota
por: Bell, Victoria, et al.
Publicado: (2018)

Immunomodulatory and Prebiotic Effects of 2′-Fucosyllactose in Suckling Rats
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2019)

Enhancing the efficiency of L-tyrosine by repeated batch fermentation
por: Li, Guohua, et al.
Publicado: (2020)

Quantifying the human milk oligosaccharides 2’‐fucosyllactose and 3‐fucosyllactose in different food applications by high‐performance liquid chromatography with refractive index detection
por: Christensen, Anne Støvlbæk, et al.
Publicado: (2020)

Human Gut Microbiota and Gastrointestinal Cancer
por: Meng, Changting, et al.
Publicado: (2018)

Update on gut microbiota in gastrointestinal diseases
por: Nishida, Atsushi, et al.
Publicado: (2022)

Editorial: Gut microbiota and gastrointestinal disorders
por: Yadegar, Abbas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_io7gm6n1p8p15sbobg2vbu0o1h